Skip to main content
Figure 3 | Particle and Fibre Toxicology

Figure 3

From: Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres

Figure 3

Pharmacokinetics and biodistribution of PEG-HAuNS. A: Blood level profiles of 64Cu-labeled PEG-HAuNS. The data are expressed as a percentage of the injected dose (5.0 mL/kg of 50 OD PEG-HAuNS, 1.25 mg/mL) per gram of blood (%ID/g) and are presented as mean ± standard deviation (n = 8). B: Biodistribution of 64Cu-labeled PEG-HAuNS in mice at 24 h after intravenous injection (n = 6).

Back to article page